国际标准期刊号: 2155-6105

成瘾研究与治疗杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 安全点亮
  • 中国知网(CNKI)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Factors Influencing AOD Counselors' Subjective Ratings of Clients? Prognoses for Post-treatment Abstention

Ashleigh Herrera

Introduction: Persons discharging from residential or inpatient substance use treatment experience the highest level of vulnerability to relapse in first three months post treatment. To support the ongoing recovery efforts of persons discharging from residential and inpatient substance use treatment, it is important to identify clients’ likely prognosis for post treatment abstinence. Subjective evaluations based on AOD counselors’ clinical impressions of the clients’ prognoses for abstention serve as an important predictor of post treatment outcomes. However, there has been limited study to date of the factors associated with AOD counselors’ subjective ratings of their clients’ prognosis for post treatment abstention.

Methods: A de-identified dataset of 200 clients admitted to abstinence-based residential SUD treatment between August 1, 2017, and March 1, 2018 was obtained. The sole dependent variable of interest in this study was the clients’ prognosis rating for abstention assigned by their primary AOD Counselor when the participants’ treatment episode ended.

Results: Based on the likelihood ratio tests, the following variables were found to be significant predictors of AOD counselor ratings for clients’ prognoses for post treatment abstention: gender (p < .028), past 30 days of use of primary substance used reported at intake (p < .001), number of lifetime inpatient psychiatric episodes (p < .026), use of alcohol and marijuana in combination (p < .026), readiness to change - no severity (p < .046), and readiness for change - mild to moderate severity (p < .025).

Conclusion: The results highlight the importance of assessment for and stabilization of psychiatric symptoms as well as withdrawal symptoms from high levels of pretreatment methamphetamine use in order to enhance treatment completion rates. Furthermore, the findings demonstrate the importance of assessing pretreatment readiness for change and motivation in order to successfully engage clients and use targeted interventions to enhance readiness to change, thereby improving treatment retention and completion rates.